UroGen Pharma
URGN
URGN
84 hedge funds and large institutions have $527M invested in UroGen Pharma in 2019 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 27 increasing their positions, 19 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
14% more funds holding
Funds holding: 74 → 84 (+10)
6% more capital invested
Capital invested by funds: $497M → $527M (+$30M)
4.88% more ownership
Funds ownership: 65.73% → 70.62% (+4.9%)
Holders
84
Holding in Top 10
4
Calls
$1.44M
Puts
$553K
Top Buyers
| 1 | +$32.9M | |
| 2 | +$10.4M | |
| 3 | +$3.7M | |
| 4 |
DG
Delek Group
Herzliya,
Israel
|
+$3.34M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.18M |
Top Sellers
| 1 | -$11.7M | |
| 2 | -$7.41M | |
| 3 | -$5.84M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.44M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.26M |